These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16794572)

  • 1. Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion.
    Song C; Li X; Kang Z; Kadotomi Y
    Neuropsychopharmacology; 2007 Mar; 32(3):736-44. PubMed ID: 16794572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats.
    Song C; Leonard BE; Horrobin DF
    Stress; 2004 Mar; 7(1):43-54. PubMed ID: 15204032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment.
    Song C; Zhang XY; Manku M
    J Neurosci; 2009 Jan; 29(1):14-22. PubMed ID: 19129380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats.
    Song C; Li X; Leonard BE; Horrobin DF
    J Lipid Res; 2003 Oct; 44(10):1984-91. PubMed ID: 12837849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration.
    Song C; Horrobin D
    J Lipid Res; 2004 Jun; 45(6):1112-21. PubMed ID: 15060086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats.
    Song C; Phillips AG; Leonard BE; Horrobin DF
    Mol Psychiatry; 2004 Jun; 9(6):630-8. PubMed ID: 14699427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.
    Pfeilschifter J; Schalkwijk C; Briner VA; van den Bosch H
    J Clin Invest; 1993 Nov; 92(5):2516-23. PubMed ID: 8227364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation.
    Kol S; Ben-Shlomo I; Payne DW; Ando M; Rohan RM; Adashi EY
    Mol Cell Endocrinol; 1998 Feb; 137(2):117-25. PubMed ID: 9605513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment.
    Taepavarapruk P; Song C
    J Neurochem; 2010 Feb; 112(4):1054-64. PubMed ID: 19968753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Schilström B; Svensson TH
    J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core.
    Jocham G; Lezoch K; Müller CP; Kart-Teke E; Huston JP; de Souza Silva MA
    Eur J Neurosci; 2006 Sep; 24(6):1721-32. PubMed ID: 17004936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
    de Souza Silva MA; Topic B; Huston JP; Mattern C
    Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
    Imperato A; Di Chiara G
    J Pharmacol Exp Ther; 1986 Oct; 239(1):219-28. PubMed ID: 3761194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice.
    van Heesch F; Prins J; Korte-Bouws GA; Westphal KG; Lemstra S; Olivier B; Kraneveld AD; Korte SM
    Behav Brain Res; 2013 Sep; 253():191-5. PubMed ID: 23896053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone attenuates depression-like changes induced by chronic central administration of interleukin-1β in rats.
    Zhang YP; Wang HY; Zhang C; Liu BP; Peng ZL; Li YY; Liu FM; Song C
    Behav Brain Res; 2018 Jul; 347():436-445. PubMed ID: 29580890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented prostaglandin E2 generation resulting from increased activities of cytosolic and secretory phospholipase A2 and induction of cyclooxygenase-2 in interleukin-1 beta-stimulated rat calvarial cells during the mineralizing phase.
    Higashi S; Ohishi H; Kudo I
    Inflamm Res; 2000 Mar; 49(3):102-11. PubMed ID: 10807497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage.
    Leistad L; Feuerherm AJ; Faxvaag A; Johansen B
    Scand J Rheumatol; 2011; 40(4):308-16. PubMed ID: 21417548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge.
    Birgner C; Kindlundh-Högberg AM; Nyberg F; Bergström L
    Neurosci Lett; 2007 Jan; 412(2):168-72. PubMed ID: 17123707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.